Manufacturer record

Ozone Pharmaceuticals Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Ozone Pharmaceuticals Ltd (Himachal Pradesh) were declared Not of Standard Quality between February 2022 and December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Ozone Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2022 to Dec 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2022
3
Products affected
Assay
Most common failure
Dec 2024
Latest alert

Flagged batches per year

2022 · 12024 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
AXBEX Suspension (Multivitamin Mulltimineral & Antioxidant Suspension) A21410Mfg 2024-05 · Exp 2025-10 Identification & Assay of CholecalciferolAssay CDL KolkataCDSCO lab Dec 2024
AXBEX Suspension (Multivitamin Mulltimineral & Antioxidant Suspension) A21411Mfg 2024-05 · Exp 2025-10 Identification & Assay of CholecalciferolAssay CDL KolkataCDSCO lab Dec 2024
Glimepride, Pioglitazone Hydrochloride & Metformin Hydrochloride (Extended Release) Tablets (OZOMET-PG 2 ) BE32456Mfg 2024-05 · Exp 2026-04 Assay of PioglitazoneAssay CDL KolkataCDSCO lab Nov 2024
Atorvastatin Tablets IP (OZOVAS-10 TABLETS) BE9047Mfg 2021-03 · Exp 2023-02 DissolutionDissolution RDTL ChandigarhState lab Feb 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.